|
|
|
||
Anticoagulant TherapyIntravenous Lovenox and PTT> Monday, November-12-2007
Dana Haas at St. Luke's Episcopal Hospital in Houston, TX asks about the effect of Lovenox on the ACT and PTT...
The Effect of Argatroban on Factor Assays> Monday, November-05-2007
On September 22 I received an e-mail question from "JLile" asking if Argatroban affects the outcomes of coagulation factor assays.
What is a critical INR?> Friday, November-02-2007Anticoagulation Forum and CYP2C9> Tuesday, October-30-2007Kim Kinney's response about monitoring for CYP2C9 polymorphisms reminded me of last summer's Anticoagulation Forum exchange between... More on the INR> Monday, October-15-2007I routinely monitor Pat Letendre's bulletin board service, Medlab-L, and lately there has been a thread discussing whether to report the INR alone or with the prothrombin time. Here is a comment from Dave McGlasson that I found to be helpful. Genomic Screening for Warfarin Therapy> Monday, October-08-2007Last Tuesday I attended a School of Public Health doctoral dissertation defense at the University of Alabama at Birmingham on the subject of testing CYP2C9 and VKORC1 polymorphisms... Should We Add AT To The Mix?> Tuesday, October-02-2007From Bob Gosselin at UC Davis: What is truth? Do we supplement with antithrombin (AT)... How Do You Monitor Arixtra?> Thursday, July-12-2007
We’ve grown accustomed to using the chromogenic anti-Xa heparin assay to monitor unfractionated (standard) heparin...
|
New! Quick Question
About this site
Fritsma Factor - the idea and the motivation
for this space Read more Topics
Guest Bloggers Our esteemed colleagues who share their knowledge and opinions here. Previous Posts
Latest Comments
Links
Subscribe to RSS feed | ||
|
|
|||
![]() |
|||